CS has changed analysts on MGR, upgraded the recommendation to Outperform - and the price surges 2.5%
MGR - MIRVAC GROUP
Credit Suisse rates MGR as Outperform (1) - Credit Suisse switches analyst on Mirvac Group and considers, amid a proliferation of negative residential news flow, demand remains robust for a quality product.
Moreover, the broker suspects Mirvac is undervalued and suggests the stock is cheap on both absolute and relative value terms.
Credit Suisse expects earnings growth of 5.3% over FY16-20 as a base case but analysis of embedded prices suggests higher margins may well drive growth closer to 6.7%. Outperform and $2.06 target retained.
Target price is $2.06 Current Price is $1.95 Difference: $0.11 If MGR meets the Credit Suisse target it will return approximately 6% (excluding dividends, fees and charges). Current consensus price target is $2.05, suggesting upside of 5.0%(ex-dividends)
Forecast for FY16: Credit Suisse forecasts a full year FY16 dividend of 10.00 cents and EPS of 13.00 cents .At the last closing share price the estimated dividend yield is 5.13%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.00.
- Forums
- ASX - By Stock
- MGR
- Credit Suisse upgrades Mirvac
Credit Suisse upgrades Mirvac
Featured News
Add MGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.18 |
Change
0.070(3.32%) |
Mkt cap ! $8.996B |
Open | High | Low | Value | Volume |
$2.14 | $2.21 | $2.12 | $45.58M | 20.89M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 827 | $2.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.19 | 180893 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 382615 | 2.760 |
25 | 1646737 | 2.750 |
12 | 602630 | 2.740 |
13 | 461695 | 2.730 |
4 | 180596 | 2.720 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 2042585 | 26 |
2.790 | 452075 | 12 |
2.800 | 127876 | 9 |
2.810 | 66829 | 3 |
2.820 | 34849 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
MGR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online